Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
75
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA

LK Billings1 Division of Endocrinology and Metabolism, NorthShore University HealthSystem, Skokie, IL, USA;2 Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
,
M Mocarski3 Value Evidence and Outcomes, Novo Nordisk Inc., Plainsboro, NJ, USA
,
A Basse4 Market Access-Region AAMEO, Novo Nordisk Pharma Gulf FZ-LLC, Dubai, United Arab Emirates
,
B Hunt5 Health Economics, Ossian Health Economics and Communications, Basel, Switzerland, [email protected]Correspondence[email protected]
,
WJ Valentine5 Health Economics, Ossian Health Economics and Communications, Basel, Switzerland, [email protected]
&
E Jodar6 Department of Endocrinology and Clinical Nutrition, H.U. Quirón Salud Madrid & Ruber Juan Bravo, Universidad Europea de Madrid, Madrid, Spain
Pages 271-282 | Published online: 21 Mar 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.